BostonGene secures SeriesA financing from NEC to support cancer treatment

BostonGene secures Series-A financing from NEC to support cancer treatment

09:27 EDT 25 Apr 2019 | Compelo Medical Devices

Founded in 2015, BostonGene has developed biomedical software solutions for use in advanced patient analysis, and evaluated its solution in close collaboration with many cancer centers across the

More From BioPortfolio on "BostonGene secures Series-A financing from NEC to support cancer treatment"